Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
GENOPTIX Add to My Watchlist (NSDQ: GXDX) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Genoptix 31.34 +0.09 (+0.29%) 138,502
1811 Aston Avenue
Carlsbad, CA 92008 US
(760) 268-6200
(760) 268-6201 fax
www.genoptix.com
CEO Dr. Tina S. Nova Bennett, Ph.D.
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US37243V1008
CIK Number 1138412
NAICS Code 621512
Business Summary
The Company is a laboratory service provider, which is focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists.
Number of Employees 301
Share Fundamentals
Market Cap 537.95M
Shares Outstanding 17.16M
Float 16.98M
Short Interest 3.15M
Financial Strength
Revenue (TTM) $169,254,000
Earnings (TTM) $28,628,000
Quick Ratio 8.7:1
Current Ratio 9.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin 64.5%
EBITDA Margin 30.9%
Profit Margin 29.9%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock Updates provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs